| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | 0.028 | 0.9 |